Showing 157 to 168 of 171 results
European Cancer Survival Disparities Highlight Urgent Need for Improved Healthcare
In 2021, cancer caused 1.1 million deaths (21.6% of total deaths) in the European Union, with survival rates varying significantly by cancer type and country due to differences in diagnosis and treatment access. Data from 29 European countries (including 24 EU countries) shows disparities in cancer ...
European Cancer Survival Disparities Highlight Urgent Need for Improved Healthcare
In 2021, cancer caused 1.1 million deaths (21.6% of total deaths) in the European Union, with survival rates varying significantly by cancer type and country due to differences in diagnosis and treatment access. Data from 29 European countries (including 24 EU countries) shows disparities in cancer ...
Progress
16% Bias Score
Alternative Cancer Therapies: Claims vs. Evidence
Despite claims from several high-profile individuals that alternative therapies like specific diets can cure cancer, major cancer organizations say there is no medical evidence supporting such claims, and some alternative therapies may even be harmful.
Alternative Cancer Therapies: Claims vs. Evidence
Despite claims from several high-profile individuals that alternative therapies like specific diets can cure cancer, major cancer organizations say there is no medical evidence supporting such claims, and some alternative therapies may even be harmful.
Progress
56% Bias Score
Canadian Cancer Costs to Reach $37.7 Billion in 2024
A Canadian Cancer Society study reveals that cancer will cost Canadian society $37.7 billion in 2024, with patients and caregivers paying $7.5 billion, highlighting financial inequities in accessing cancer care; the study projects that cost to rise to $37.4 billion annually by 2034.
Canadian Cancer Costs to Reach $37.7 Billion in 2024
A Canadian Cancer Society study reveals that cancer will cost Canadian society $37.7 billion in 2024, with patients and caregivers paying $7.5 billion, highlighting financial inequities in accessing cancer care; the study projects that cost to rise to $37.4 billion annually by 2034.
Progress
28% Bias Score
Glioblastoma Death Highlights Projected 75% Increase in Cases by 2050
Fox News commentator Dr. Kelly Powers, 45, died from glioblastoma, a brain cancer projected to increase by 75 percent by 2050 due to pollution and chemical exposure; despite treatments, she passed away last week leaving behind a young son.
Glioblastoma Death Highlights Projected 75% Increase in Cases by 2050
Fox News commentator Dr. Kelly Powers, 45, died from glioblastoma, a brain cancer projected to increase by 75 percent by 2050 due to pollution and chemical exposure; despite treatments, she passed away last week leaving behind a young son.
Progress
40% Bias Score
Parma Hospital Launches Music Therapy Program for Cancer Patients
The Orchestra Dedicata, an ensemble of professional musicians, will perform eight concerts for cancer patients at Parma's Maggiore Hospital from November to June, providing therapeutic music in oncology, radiotherapy, and day hospital wards, thanks to support from donors including GAR srl and collab...
Parma Hospital Launches Music Therapy Program for Cancer Patients
The Orchestra Dedicata, an ensemble of professional musicians, will perform eight concerts for cancer patients at Parma's Maggiore Hospital from November to June, providing therapeutic music in oncology, radiotherapy, and day hospital wards, thanks to support from donors including GAR srl and collab...
Progress
24% Bias Score
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Progress
48% Bias Score
Gleason Score: Key to Prostate Cancer Treatment Decisions
Prostate cancer diagnosis uses the Gleason score (6-10), from biopsy samples, to determine cancer aggressiveness; higher scores indicate faster growth and spread, influencing treatment decisions; a revised system offers finer risk stratification.
Gleason Score: Key to Prostate Cancer Treatment Decisions
Prostate cancer diagnosis uses the Gleason score (6-10), from biopsy samples, to determine cancer aggressiveness; higher scores indicate faster growth and spread, influencing treatment decisions; a revised system offers finer risk stratification.
Progress
32% Bias Score
World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...
World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...
Progress
56% Bias Score
Doctor's Relentless Battle with Recurring Breast Cancer
Cat Stone, a 43-year-old Auckland-based doctor, was diagnosed with grade 2 hormonal breast cancer in 2020, experienced recurrence in 2021 and 2024, and is now facing aggressive chemotherapy and radiation after a recent diagnosis of multiple invasive cancers and a large pre-cancerous lump.
Doctor's Relentless Battle with Recurring Breast Cancer
Cat Stone, a 43-year-old Auckland-based doctor, was diagnosed with grade 2 hormonal breast cancer in 2020, experienced recurrence in 2021 and 2024, and is now facing aggressive chemotherapy and radiation after a recent diagnosis of multiple invasive cancers and a large pre-cancerous lump.
Progress
8% Bias Score
Immune System Boosting: Cancer Treatment vs. Vitamin Supplements
Boosting the immune system, while effective against cancer, causes autoimmune diseases in over half of treated cancer patients. However, vitamin supplements have minimal impact on immunity, except for Vitamin A deficiency in some children.
Immune System Boosting: Cancer Treatment vs. Vitamin Supplements
Boosting the immune system, while effective against cancer, causes autoimmune diseases in over half of treated cancer patients. However, vitamin supplements have minimal impact on immunity, except for Vitamin A deficiency in some children.
Progress
40% Bias Score
Ovarian Tissue Cryopreservation Offers Hope to Young Cancer Patient
A nine-year-old Alberta girl underwent ovarian tissue cryopreservation to preserve her fertility after being diagnosed with a dangerous genetic mutation, highlighting a new approach to cancer treatment and fertility preservation in Canada, where the procedure is not publicly funded but is offered in...
Ovarian Tissue Cryopreservation Offers Hope to Young Cancer Patient
A nine-year-old Alberta girl underwent ovarian tissue cryopreservation to preserve her fertility after being diagnosed with a dangerous genetic mutation, highlighting a new approach to cancer treatment and fertility preservation in Canada, where the procedure is not publicly funded but is offered in...
Progress
48% Bias Score
High-Dose Vitamin C Doubles Survival Rate in Pancreatic Cancer Study
A phase 2 clinical trial at the University of Iowa Health Care found that adding 75 grams of intravenous vitamin C three times a week to chemotherapy for late-stage pancreatic cancer doubled overall survival rates to 16 months and increased progression-free survival to six months.
High-Dose Vitamin C Doubles Survival Rate in Pancreatic Cancer Study
A phase 2 clinical trial at the University of Iowa Health Care found that adding 75 grams of intravenous vitamin C three times a week to chemotherapy for late-stage pancreatic cancer doubled overall survival rates to 16 months and increased progression-free survival to six months.
Progress
40% Bias Score
Showing 157 to 168 of 171 results